Researchers in Singapore have developed a diagnostic kit that could help diagnose Alzheimer’s disease using a simple blood test.
When combined with microfluidics and antibodies, graphene can become a powerful bacteria biosensor, researchers say.
The Philips Azurion 7 C20 with FlexArm augments image guided therapy workflows and grants medical teams unprecedented flexibility in hybrid operating rooms.
Researchers in Japan have developed a fast, accurate and fully automated device that can measure the extent of α-synuclein aggregation in the cerebrospinal fluid of patients with Parkinson's disease.
Researchers in Hong Kong have developed a palm-sized 3D ultrasound imaging system that could allow mass screening for scoliosis.
Using their adhesive biosensor, researchers in China were able to measure the pH of sweat, as well as the concentration of glucose, calcium and chloride in the biofluid.
By injecting contrast agent into upstream lymph nodes, scientists in Japan were able to detect cancer cells within the lymphatic system early on.
Scientists in Hong Kong and the UK have devised a method to monitor hormone pulse patterns in patients with reproductive disorders.
The acquisition will allow PHC Holdings Corporation to expand its portfolio of products and services across diabetes care, diagnostics, life sciences and healthcare IT.